PHARMACEUTICAL COMPOSITION CONTAINING HISTONE DEACETYLASE INHIBITOR
An anticancer drug having a synergistic effect by combined use of a histone acetylase derivative such as N-(2-aminophenyl)-4-[N- (pyridin-3- ylmethoxycarbonyl) aminomethyl]benzamide (MS-275) and another anticancer active substance. Opisan je lek protiv raka koji obezbeđuje sinergističko dejstvo deri...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English Serbian |
Published |
04.04.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | An anticancer drug having a synergistic effect by combined use of a histone acetylase derivative such as N-(2-aminophenyl)-4-[N- (pyridin-3- ylmethoxycarbonyl) aminomethyl]benzamide (MS-275) and another anticancer active substance.
Opisan je lek protiv raka koji obezbeđuje sinergističko dejstvo derivata benzamida, kao što N-(2-aminofenil)-4-[N-(piridin-3-ilmetoksikarbonil)aminoetil]benzamid (MS-275), koji je inhibitor histonske deacetilaze, prilikom kombinovane upotrebe sa još jednom aktivnom antikancerskom supstancom. |
---|---|
Bibliography: | Application Number: YU2005P000884 |